NorthRock Partners’s Medpace MEDP Stock Holding History

NorthRock Partners’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-919	Closed	-$473K	–	799
2025 Q3	$473K	Buy	+919	New	+$401K	0.01%	551

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

NorthRock Partners's MEDP Position: Q4 2025 in Review

NorthRock Partners sold out of Medpace (MEDP) in Q4 2025, closing a stake of 919 shares — an estimated $473K sold.

NorthRock Partners first reported a position in MEDP in Q3 2025 and held it in 1 quarter. The position peaked at $473K in Q3 2025. 787 funds tracked by Wall St. Rank hold MEDP as of Q4 2025.

NorthRock Partners reported no remaining Medpace position as of Q4 2025 after selling out during the quarter.
NorthRock Partners sold 919 Medpace shares in Q4 2025, an estimated $473K.
NorthRock Partners first reported a position in Medpace in Q3 2025 and held it in 1 quarter.
NorthRock Partners's Medpace position peaked at $473K in Q3 2025.
787 funds tracked by Wall St. Rank held Medpace as of Q4 2025.

Based on NorthRock Partners's 13F filing for Q4 2025, filed 17 Feb 2026.